- Home
- RIV vs ZYXI Comparison
RIV vs ZYXI Comparison
Compare RIV & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIV
- ZYXI
- Stock Information
- Founded
- RIV 2015
- ZYXI 1996
- Country
- RIV United States
- ZYXI United States
- Employees
- RIV N/A
- ZYXI N/A
- Industry
- RIV Finance Companies
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RIV Finance
- ZYXI Health Care
- Exchange
- RIV Nasdaq
- ZYXI Nasdaq
- Market Cap
- RIV 267.3M
- ZYXI 265.0M
- IPO Year
- RIV N/A
- ZYXI N/A
- Fundamental
- Price
- RIV $11.86
- ZYXI $8.17
- Analyst Decision
- RIV
- ZYXI Strong Buy
- Analyst Count
- RIV 0
- ZYXI 2
- Target Price
- RIV N/A
- ZYXI $14.00
- AVG Volume (30 Days)
- RIV 87.6K
- ZYXI 54.5K
- Earning Date
- RIV 01-01-0001
- ZYXI 10-24-2024
- Dividend Yield
- RIV 12.85%
- ZYXI N/A
- EPS Growth
- RIV N/A
- ZYXI N/A
- EPS
- RIV N/A
- ZYXI 0.15
- Revenue
- RIV N/A
- ZYXI $193,665,000.00
- Revenue This Year
- RIV N/A
- ZYXI $10.70
- Revenue Next Year
- RIV N/A
- ZYXI $19.78
- P/E Ratio
- RIV N/A
- ZYXI $56.20
- Revenue Growth
- RIV N/A
- ZYXI 4.21
- 52 Week Low
- RIV $9.63
- ZYXI $7.15
- 52 Week High
- RIV $12.43
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- RIV 24.64
- ZYXI 48.12
- Support Level
- RIV $12.41
- ZYXI $8.06
- Resistance Level
- RIV $12.45
- ZYXI $8.62
- Average True Range (ATR)
- RIV 0.16
- ZYXI 0.28
- MACD
- RIV -0.06
- ZYXI 0.02
- Stochastic Oscillator
- RIV 0.00
- ZYXI 45.12
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.